Marketing Challenges
- To determine patients’ preferences in the administration and dosage regimen of a specific medication compared with three different Biologic DMARD agents
- To determine potential impact on prescription rates
Creative Strategy
Conducted face-to-face interviews with pre-qualified Rheumatoid Arthritis and Psoriatic Arthritis patients to assess mode of administration preferences of three FDA-approved Biologic DMARD agents.
Media Mix
In collaboration with the sponsor, DAC developed the study protocol and screening and interview questionnaires. A marketing communications company developed storyboards derived from information obtained in the package insert, product labeling and patient starter kits for each Biologic DMARD.
Results
Key parameters assessed included:
- Comparative evaluation of administration approaches
- Overall preferred administrative approach
- Self-injection product comparison questions
Among patients who expressed a preference for one of the self-injectables, each subgroup expressed a strong preference for the dosing frequency presented in storyboard N1 over N2 (weekly dosing).
The results of this study suggest a strong preference for the method, convenience of administration and dosing frequency for the medication.
